Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Lichen International (LICN) Receivables - Other (2021 - 2025)

On a quarterly basis, Receivables - Other fell 58.87% to $292000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $292000.0, a 58.87% decrease, with the full-year FY2025 number at $292000.0, down 58.87% from a year prior.

Lichen International (LICN) has 5 years of Receivables - Other data on record, last reported at $292000.0 in Q4 2025.

  • Receivables - Other reached $292000.0 in Q4 2025 per LICN's latest filing, down from $710000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for LICN hit a ceiling of $804000.0 in Q4 2023 and a floor of $106000.0 in Q4 2021.
  • A 5-year average of $468000.0 and a median of $428000.0 in 2022 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: surged 303.77% in 2022, then plummeted 58.87% in 2025.
  • Tracing LICN's Receivables - Other over 5 years: stood at $106000.0 in 2021, then soared by 303.77% to $428000.0 in 2022, then surged by 87.85% to $804000.0 in 2023, then fell by 11.69% to $710000.0 in 2024, then tumbled by 58.87% to $292000.0 in 2025.
  • Business Quant data shows Receivables - Other for LICN at $292000.0 in Q4 2025, $710000.0 in Q4 2024, and $804000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Relx 81.40 Bn 81.16 Bn -
2 Rentokil Initial 79.56 Bn 78.10 Bn -
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn
10 Lichen International 4.85 Mn -22.06 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 292,000.00
Dec 31, 2025 292,000.00
Dec 31, 2024 710,000.00
Dec 31, 2024 710,000.00
Dec 31, 2023 804,000.00
Dec 31, 2023 804,000.00
Dec 31, 2022 428,000.00
Dec 31, 2022 428,000.00
Dec 31, 2021 106,000.00
Dec 31, 2021 106,000.00